We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Verizon (VZ), Abbott (ABT), Thermo Fisher (TMO) Report Q3; Tesla (TSLA) After the Bell
Read MoreHide Full Article
Wednesday, October 21, 2020
Q3 earnings season dominates the headlines this morning, with no major economic releases hitting the tape ahead of today’s market open, and hopes of a stimulus deal from Congress once again on the wane. Fed official Lael Brainard gave another warning this morning about the negative affect a lack of stimulus will have on the U.S. labor market, but to this point the two sides look too far apart to reach a deal.
Verizon (VZ - Free Report) posted a 3-cent beat to $1.25 per share in its Q3 report, with revenues coming in close to dead-even (-0.09%) at $31.54 billion. Sales year over year have also come down a tad, although guidance for full-year 2020 is up, as were subscriber adds overall in Q3. Shares are up 0.75% on the news ahead of the bell, but still -6% year to date. For more on VZ’s earnings, click here.
Abbott Labs (ABT - Free Report) beat the Zacks consensus by 8 cents to 98 cents per share in its Q3 earnings release this morning, with quarterly sales up 4.67% from expectations to $8.85 billion. The pharma major, located in the Chicago suburbs, received “emergency use” status for its Covid-19 rapid test in August, which has helped bolster the company’s near-term outlook. Guidance for full-year earnings is now $3.55 per share on the bottom end, 5 cents higher than the Zacks consensus prior to the report. For more on ABT’s earnings, click here.
Thermo Fisher (TMO - Free Report) , a Zacks #1 (Strong Buy) stock ahead of its Q3 earnings, put up impressive beats on both top and bottom lines: $5.63 per share was well ahead of the $4.37 our analysts were expecting, with $8.52 billion in sales beating estimates by 10%. This medical products manufacturer, with a wide portfolio offering from instruments to antibodies, was already up 43% year to date, and has gained another 3.5% on its earnings news. The company also has not posted a quarterly earnings miss since Q4 2009! For more on TMO’s earnings, click here.
After the closing bell this afternoon, we look forward to earnings reports from noteworthy companies like Chipotle (CMG - Free Report) and CSX Corp. (CSX - Free Report) . But much of the attention will be given to Tesla (TSLA - Free Report) , which reports Q3 earnings later today.
Tesla is currently on track to post its first yearly profit in the company’s history. Expectations currently are for earnings of 55 cents per share in Q3, up 48.65% year over year, on $8.29 billion in sales, which is +31.45% from a year ago. The company has beaten in the past 4 quarters, by an average of +645% — based on a whopping +1340% surprise in the September quarter of 2019. Previous to that, Tesla had disappointed investors on the bottom line in 6 of its prior 10 quarters, going back to 2017.
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
Image: Bigstock
Verizon (VZ), Abbott (ABT), Thermo Fisher (TMO) Report Q3; Tesla (TSLA) After the Bell
Wednesday, October 21, 2020
Q3 earnings season dominates the headlines this morning, with no major economic releases hitting the tape ahead of today’s market open, and hopes of a stimulus deal from Congress once again on the wane. Fed official Lael Brainard gave another warning this morning about the negative affect a lack of stimulus will have on the U.S. labor market, but to this point the two sides look too far apart to reach a deal.
Verizon (VZ - Free Report) posted a 3-cent beat to $1.25 per share in its Q3 report, with revenues coming in close to dead-even (-0.09%) at $31.54 billion. Sales year over year have also come down a tad, although guidance for full-year 2020 is up, as were subscriber adds overall in Q3. Shares are up 0.75% on the news ahead of the bell, but still -6% year to date. For more on VZ’s earnings, click here.
Abbott Labs (ABT - Free Report) beat the Zacks consensus by 8 cents to 98 cents per share in its Q3 earnings release this morning, with quarterly sales up 4.67% from expectations to $8.85 billion. The pharma major, located in the Chicago suburbs, received “emergency use” status for its Covid-19 rapid test in August, which has helped bolster the company’s near-term outlook. Guidance for full-year earnings is now $3.55 per share on the bottom end, 5 cents higher than the Zacks consensus prior to the report. For more on ABT’s earnings, click here.
Thermo Fisher (TMO - Free Report) , a Zacks #1 (Strong Buy) stock ahead of its Q3 earnings, put up impressive beats on both top and bottom lines: $5.63 per share was well ahead of the $4.37 our analysts were expecting, with $8.52 billion in sales beating estimates by 10%. This medical products manufacturer, with a wide portfolio offering from instruments to antibodies, was already up 43% year to date, and has gained another 3.5% on its earnings news. The company also has not posted a quarterly earnings miss since Q4 2009! For more on TMO’s earnings, click here.
After the closing bell this afternoon, we look forward to earnings reports from noteworthy companies like Chipotle (CMG - Free Report) and CSX Corp. (CSX - Free Report) . But much of the attention will be given to Tesla (TSLA - Free Report) , which reports Q3 earnings later today.
Tesla is currently on track to post its first yearly profit in the company’s history. Expectations currently are for earnings of 55 cents per share in Q3, up 48.65% year over year, on $8.29 billion in sales, which is +31.45% from a year ago. The company has beaten in the past 4 quarters, by an average of +645% — based on a whopping +1340% surprise in the September quarter of 2019. Previous to that, Tesla had disappointed investors on the bottom line in 6 of its prior 10 quarters, going back to 2017.
Questions or comments about this article and/or its author? Click here>>
These Stocks Are Poised to Soar Past the Pandemic
The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.
Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.
See the 5 high-tech stocks now>